Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-15 BLECH ISAAC Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 Crane Rosemary A Director Exercise or conversion +10,000 10,000
2019-03-15 Crane Rosemary A Director Exercise or conversion · Restricted Stock Units −10,000 0
2019-03-15 BARER SOL J Director Exercise or conversion +20,000 678,075
2019-03-15 BARER SOL J Director Exercise or conversion · Restricted Stock Units −20,000 0
2018-08-14 Macdonald R. Loch Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 Crane Rosemary A Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 Ratcliffe Liam Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 LOUGHLIN JAMES J Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 BLECH ISAAC Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 MARCHIO ALBERT N II Chief Accounting & Adm Officer Grant or award · Restricted Stock Units +41,666 41,666
2018-08-14 Saik Andrew Chief Financial Officer Grant or award · Restricted Stock Units +82,999 82,999
2018-08-14 Wyant Alyssa SVP Regulatory Affairs Grant or award · Restricted Stock Units +49,766 49,766
2018-08-14 Spiegel Robert J. Director Grant or award · Restricted Stock Units +10,000 10,000
2018-08-14 BARER SOL J Director Grant or award · Restricted Stock Units +20,000 20,000
2018-08-14 Faleck Herbert J Chief Medical Officer Grant or award · Restricted Stock Units +59,833 59,833
2018-08-14 Leuthner Brian A President and CEO Grant or award · Restricted Stock Units +169,032 169,032
2018-08-14 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Restricted Stock Units +49,766 49,766
2018-06-19 BLECH ISAAC Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2018-06-19 Ratcliffe Liam Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000

Page 8 of 18 · 346 trades